Compare PLSE & SGRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | SGRY |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2015 | 2015 |
| Metric | PLSE | SGRY |
|---|---|---|
| Price | $24.58 | $13.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | $22.00 | ★ $22.25 |
| AVG Volume (30 Days) | 303.9K | ★ 1.4M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.14 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,145,438,000.00 |
| Revenue This Year | $840.00 | $5.09 |
| Revenue Next Year | $287.54 | $5.67 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.56 | $11.41 |
| 52 Week High | $27.98 | $24.10 |
| Indicator | PLSE | SGRY |
|---|---|---|
| Relative Strength Index (RSI) | 58.84 | 49.31 |
| Support Level | $17.58 | $13.33 |
| Resistance Level | $26.30 | $15.11 |
| Average True Range (ATR) | 1.77 | 0.71 |
| MACD | 0.54 | -0.06 |
| Stochastic Oscillator | 64.24 | 29.21 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.